NCT03465410View on ClinicalTrials.gov

OPTImization of the Dose of tacroliMUS by Bayesian Prediction

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

March 21, 2017

Primary Completion Date

September 21, 2020

Study Completion Date

September 21, 2020

Conditions
KIDNEY TRANSPLANTATION
Interventions
DRUG

Standard dosage of Tacrolimus

Immediate release Tacrolimus (Prograf/Adoport)

DRUG

Bayesian Prediction Tacrolimus dosage

Immediate release Tacrolimus (Prograf/Adoport)

Trial Locations (2)

Unknown

Hospital Universitari de la Vall d'Hebron, Barcelona

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

NURIA LLOBERAS BLANCH

OTHER

NCT03465410 - OPTImization of the Dose of tacroliMUS by Bayesian Prediction | Biotech Hunter | Biotech Hunter